Research Article Details
| Article ID: | A26781 |
| PMID: | 19795023 |
| Source: | J Gastrointestin Liver Dis |
| Title: | Does weight history affect fibrosis in the setting of chronic liver disease? |
| Abstract: | AIM: To evaluate weight history in chronic liver disease and assess for associations with advanced fibrosis. Weight and Lifestyle Inventory (WALI) was used to assess lifelong weight and eating habits. RESULTS: 38 patients had a diagnosis of nonalcoholic fatty liver disease (NAFLD) and 37 had other chronic liver disease. The body mass index (BMI) did not predict the presence of advanced fibrosis. The time with BMI over 30 kg/m2 was 19.2 years+/-15.7 with advanced fibrosis and 8.6 years+/-10.4 in the non-advanced group (p=0.002). Independent predictors of fibrosis were: 1) Non-NAFLD (OR 6.2); 2) obesity, with a BMI over 30 for more than 15 years (OR 12.4); 3) at least moderate alcohol use (OR 12.2); 4) advanced age (OR 3.3). Weight history did not impact NALFD differently from Non-NAFLD. CONCLUSIONS: BMI over 30 for more than 15 years increases the risk of advanced fibrosis in all chronic liver diseases, on par with the risk of alcohol ingestion. |
| DOI: |
| Strategy ID | Therapy Strategy | Synonyms | Therapy Targets | Therapy Drugs | |
|---|---|---|---|---|---|
| S03 | Anti-fibrosis | fibrosis | Angiotensin Receptor Blocker (ARB); CCR2/CCR5 antagonist; Thyroid receptor β agonist; PEGylated human FGF21 analogue; Monoclonal antibody to lysyl oxidase-like 2 (LOXL2); Galectin-3 inhibitor; FGF19 variant | Losartan; Cenicriviroc; VK-2809; MGL-3196; Pegbelfermin; Simtuzumab; GR-MD-02; NGM282 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class | |
|---|---|---|---|---|---|
| I14 | 9970 | Obesity | An overnutrition that is characterized by excess body fat, traditionally defined as an elevated ratio of weight to height (specifically 30 kilograms per meter squared), has_material_basis_in a multifactorial etiology related to excess nutrition intake, decreased caloric utilization, and genetic susceptibility, and possibly medications and certain disorders of metabolism, endocrine function, and mental illness. https://en.wikipedia.org/wiki/Obesity | disease of metabolism/acquired metabolic disease/ nutrition disease/overnutrition | Details |